Menu
1-702-720-6310 info@microcapspecualtors.com

Which Biotech Earnings Will Outperform? – Barron’s


Barron’s

Which Biotech Earnings Will Outperform?
Barron’s
The firm writes that investors should expect a “solid but not spectacular” second-quarter earnings season for biotech as a whole. That said, they think the companies that are most likely to beat consensus expectations are Alexion (ALXN) Biogen (BIIB) …

Search